ClinicaliQ Trial Snapshot
- A Study of Zigakibart in Adults With IgA Nephropathy — Active Not Recruiting • Phase III • NCT05852938.
- Review the linked registry entry for study design, population, endpoints, and operational status.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy Conditions: IgA Nephropathy, Immunoglobulin A Nephropathy Interventions: BION-1301, Placebo Lead Sponsor: Novartis Pharmaceuticals Planned Enrollment: 383 participants